TE Connectivity
Official SEC filings
Source: SEC EDGAR. Latest available cached filings; filing date is not the financial period end. Index checked: 2026-11-22 02:43 UTC.
| Form | Filed | Original document |
|---|---|---|
| 10-K | 2026-11-09 | Read on SEC.gov |
| 8-K | 2026-11-02 | Read on SEC.gov |
| 8-K | 2026-10-28 | Read on SEC.gov |
| 8-K | 2026-10-07 | Read on SEC.gov |
| 10-Q | 2026-07-24 | Read on SEC.gov |
| 8-K | 2026-07-22 | Read on SEC.gov |
| 10-Q | 2026-04-24 | Read on SEC.gov |
| 8-K | 2026-04-22 | Read on SEC.gov |
SEC annual financial snapshot
Standard US-GAAP facts in 10-K filings, USD. Income and cash flow cover the annual period; balance-sheet amounts are as of period end. These are not quarterly or TTM figures. Latest available filed values may include restatements; reporting periods can differ from other providers. Checked: 2026-11-22 04:51 UTC.
| Metric | USD | Basis | Period end | Filed | Source |
|---|---|---|---|---|---|
| Revenue | $19.89B | Annual | 2026-09-25 | 2026-11-09 | 10-K |
| Net income | $3.25B | Annual | 2026-09-25 | 2026-11-09 | 10-K |
| Operating cash flow | $4.53B | Annual | 2026-09-25 | 2026-11-09 | 10-K |
| Total assets | $26.67B | As of | 2026-09-25 | 2026-11-09 | 10-K |
| Total liabilities | $12.95B | As of | 2026-09-25 | 2026-11-09 | 10-K |
| Cash and cash equivalents | $1.70B | As of | 2026-09-25 | 2026-11-09 | 10-K |
✦ Quant Financial Health how this is computed
- Altman Z-Score is 4.89, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
✦ Quant Revenue Concentration how this is computed
- Industrial solutions is the largest reported line at 50.00% of revenue, across 2 reported segments.
- Transportation Solutions follows at 50.00%, so the top line still matters most but isn’t the whole story.
Revenue annual, last 8 years
Latest year +15.20% YoY
Margins
- Gross margin
- 36.24%
- Operating margin
- 20.82%
- Net margin
- 16.36%
Key ratios & quality
- Enterprise valuei
- 61.40B
- PEG ratioi
- 0.93
- Altman Z-Scorei
- 4.89
PEG uses trailing P/E against the 3-year net income growth rate (19.42%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 13.45B | 12.17B | 14.92B | 16.28B | 16.03B | 15.85B | 17.26B | 19.89B |
| Gross profit | 4.39B | 3.74B | 4.89B | 5.24B | 5.06B | 5.46B | 6.08B | 7.21B |
| Selling & admin expenses | 1.49B | 1.39B | 1.51B | 1.58B | 1.67B | 1.73B | 1.87B | 2.12B |
| Research & development | 644.00M | 613.00M | 677.00M | 718.00M | 708.00M | 741.00M | 829.00M | 942.00M |
| Operating profit | 2.26B | 1.73B | 2.70B | 2.94B | 2.68B | 2.98B | 3.38B | 4.14B |
| Pretax profit | 1.93B | 524.00M | 2.38B | 2.73B | 2.27B | 2.80B | 3.20B | 3.95B |
| Tax | -15.00M | 783.00M | 123.00M | 306.00M | 364.00M | -397.00M | 1.36B | 695.00M |
| Net profit | 1.84B | -241.00M | 2.26B | 2.43B | 1.91B | 3.19B | 1.84B | 3.25B |
| Basic EPS | 5 | -1 | 7 | 8 | 6 | 10 | 6 | 11 |
| Diluted EPS | 5.42 | -0.73 | 6.79 | 7.47 | 6.03 | 10.33 | 6.16 | 11.06 |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Revenue | 4.53B | 4.75B | 4.67B | 4.74B | 5.16B | 5.31B |
| Gross profit | 1.60B | 1.66B | 1.74B | 1.75B | 1.84B | 1.89B |
| Selling & admin expenses | 491.00M | 494.00M | 538.00M | 536.00M | 532.00M | 518.00M |
| Research & development | 211.00M | 227.00M | 225.00M | 237.00M | 230.00M | 250.00M |
| Operating profit | 898.00M | 939.00M | 976.00M | 972.00M | 1.07B | 1.12B |
| Pretax profit | 846.00M | 897.00M | 961.00M | 942.00M | 971.00M | 1.08B |
| Tax | 208.00M | 233.00M | 210.00M | 87.00M | 223.00M | 175.00M |
| Net profit | 638.00M | 663.00M | 750.00M | 855.00M | 748.00M | 900.00M |
| Basic EPS | 2 | 2 | 3 | 3 | 3 | 3 |
| Diluted EPS | 2.14 | 2.22 | 2.53 | 2.90 | 2.55 | 3.09 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 5.55B | 5.78B | 7.26B | 7.27B | 7.89B | 7.63B | 7.97B | 9.28B |
| Cash & ST investments | 927.00M | 945.00M | 1.20B | 1.09B | 1.66B | 1.32B | 1.26B | 1.70B |
| Inventory | 1.84B | 1.95B | 2.51B | 2.68B | 2.55B | 2.52B | 2.70B | 2.96B |
| Total assets | 19.69B | 19.24B | 21.46B | 20.78B | 21.71B | 22.85B | 25.08B | 26.67B |
| Total current liabilities | 3.54B | 3.69B | 4.66B | 4.63B | 4.46B | 4.75B | 5.12B | 5.36B |
| Short-term debt | 570.00M | 810.00M | 621.00M | 1.04B | 800.00M | 999.00M | 978.00M | 633.00M |
| Long-term debt | 3.40B | 3.45B | 3.59B | 3.29B | 3.53B | 3.33B | 4.84B | 5.14B |
| Total liabilities | 9,124,000,000.00 | 9,747,000,000.00 | 10,714,000,000.00 | 9,885,000,000.00 | 10,057,000,000.00 | 10,368,000,000.00 | 12,351,000,000.00 | 12,949,000,000.00 |
| Total equity | 10.57B | 9.50B | 10.75B | 10.90B | 11.66B | 12.49B | 12.73B | 13.72B |
| Retained earnings | 12.26B | 10.35B | 11.71B | 12.83B | 12.95B | 14.53B | 13.93B | 15.24B |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Total current assets | 7.61B | 7.97B | 8.37B | 8.24B | 8.74B | 9.28B |
| Cash & ST investments | 672.00M | 1.26B | 1.25B | 1.11B | 1.24B | 1.70B |
| Inventory | 2.83B | 2.70B | 2.95B | 3.00B | 3.03B | 2.96B |
| Total assets | 24.87B | 25.08B | 25.55B | 25.68B | 26.07B | 26.67B |
| Total current liabilities | 4.99B | 5.12B | 5.07B | 4.37B | 4.66B | 5.36B |
| Short-term debt | 851.00M | 978.00M | 852.00M | 102.00M | 102.00M | 633.00M |
| Long-term debt | 4.85B | 4.84B | 4.86B | 5.55B | 5.53B | 5.14B |
| Total liabilities | 12,342,000,000.00 | 12,351,000,000.00 | 12,416,000,000.00 | 12,297,000,000.00 | 12,677,000,000.00 | 12,949,000,000.00 |
| Total equity | 12.52B | 12.73B | 13.14B | 13.38B | 13.39B | 13.72B |
| Retained earnings | 13.34B | 13.93B | 14.54B | 13.90B | 14.50B | 15.24B |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 2.42B | 1.99B | 2.68B | 2.47B | 3.13B | 3.48B | 4.14B | 4.53B |
| Depreciation & amortization | 690.00M | 711.00M | 769.00M | 785.00M | 794.00M | 826.00M | 838.00M | 1.03B |
| Free cash flow | 1.67B | 1.43B | 1.99B | 1.70B | 2.40B | 2.80B | 3.20B | 3.40B |
| Dividends paid | -608.00M | -625.00M | -647.00M | -685.00M | -725.00M | -760.00M | -803.00M | -869.00M |
| Stock buybacks / issuance | -1.09B | -523.00M | -831.00M | -1.41B | -945.00M | -2.06B | -1.35B | -1.89B |
| Ending cash balance | 927.00M | 945.00M | 1.20B | 1.09B | 1.66B | 1.32B | 1.26B | 1.70B |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Operating cash flow | 1.19B | 1.42B | 865.00M | 947.00M | 1.19B | 1.53B |
| Depreciation & amortization | 216.00M | 244.00M | 259.00M | 243.00M | 256.00M | 275.00M |
| Free cash flow | 957.00M | 1.15B | 607.00M | 677.00M | 881.00M | 1.24B |
| Dividends paid | -212.00M | -209.00M | -209.00M | -208.00M | -226.00M | -226.00M |
| Stock buybacks / issuance | -301.00M | -437.00M | -405.00M | -414.00M | -529.00M | -544.00M |
| Ending cash balance | 672.00M | 1.26B | 1.25B | 1.11B | 1.24B | 1.70B |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 17.23 | -2.42 | 22.59 | 22.65 | 17.09 | 26.71 | 14.77 | 24.87 |
| ROA %i | 9.20 | -1.24 | 11.11 | 11.50 | 8.99 | 14.33 | 7.69 | 12.57 |
| ROIC %i | 12.81 | -1.53 | 16.13 | 16.50 | 12.43 | 19.53 | 10.47 | 17.38 |
| 5-year avg ROE %i | 21.78 | 16.09 | 16.16 | 17.00 | 15.43 | 17.33 | 20.76 | 21.22 |
| EBIT margin %i | 14.86 | 4.70 | 16.31 | 17.19 | 14.64 | 18.09 | 19.01 | 20.49 |
| FCF / sales %i | 12.44 | 11.76 | 13.31 | 10.44 | 14.97 | 17.65 | 18.56 | 17.11 |
| Current ratioi | 1.57 | 1.57 | 1.56 | 1.57 | 1.77 | 1.61 | 1.56 | 1.73 |
| Quick ratioi | 0.92 | 0.90 | 0.89 | 0.85 | 1.04 | 0.92 | 0.91 | 1.03 |
| Debt / assetsi | 20.13 | 22.15 | 19.62 | 20.85 | 19.94 | 18.95 | 23.20 | 21.63 |
| LT debt / equityi | 32.12 | 36.79 | 33.75 | 30.48 | 30.55 | 26.97 | 38.47 | 37.85 |
| Interest coveragei | 29.40 | 11.92 | 43.46 | 42.41 | 29.35 | 40.96 | 42.61 | 32.85 |
| Revenue CAGR (3Y) %i | 5.81 | -0.04 | 2.18 | 6.58 | 9.62 | 2.02 | 1.97 | 7.44 |
| Net income CAGR (3Y) %i | -2.82 | -- | -4.12 | 9.60 | -- | 12.19 | -8.80 | 19.42 |
| FCF CAGR (3Y) %i | 7.57 | -4.46 | 9.42 | 0.54 | 18.78 | 12.09 | 23.51 | 12.34 |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| ROE %i | 11.63 | 14.77 | 16.25 | 22.96 | 23.54 | 24.87 |
| ROA %i | 6.09 | 7.69 | 8.60 | 11.78 | 11.84 | 12.57 |
| ROIC %i | 8.23 | 10.47 | 11.76 | 16.04 | 16.47 | 17.38 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 18.26 | 19.01 | 19.67 | 20.14 | 20.15 | 20.49 |
| FCF / sales %i | 17.38 | 18.56 | 17.34 | 18.14 | 17.16 | 17.11 |
| Current ratioi | 1.52 | 1.56 | 1.65 | 1.89 | 1.88 | 1.73 |
| Quick ratioi | 0.82 | 0.91 | 0.93 | 1.05 | 1.07 | 1.03 |
| Debt / assetsi | 22.91 | 23.20 | 22.34 | 22.02 | 21.60 | 21.63 |
| LT debt / equityi | 39.14 | 38.47 | 37.39 | 41.96 | 41.75 | 37.85 |
| Interest coveragei | 48.05 | 42.61 | 35.25 | 31.64 | 31.91 | 32.85 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Quote time 2026-11-20 20:02:16 · For reference only, not investment advice and not tailored to your situation.
TE Connectivity discussion 0 comments